FHTX today
$2.07+$0.02 (+0.98%)close Nov 13, 2026Trend
DailyDowntrend (starting)
4 hourExpanding
1 hourStrong Bullish
15 minStrong Bullish
5 minStrong Bullish
Daily trend turns up above $7.61
Key levels
Resistance$2.94
Resistance$2.70
Support$1.79
Latest news & SEC filings
SEC FilingFoghorn Therapeutics Inc. filed a report on a major company event (Form 8-K)
All FHTX news →About Foghorn Therapeutics
Foghorn Therapeutics is a clinical-stage biotechnology company developing precision medicines that target the chromatin regulatory system to correct abnormal gene expression. Its lead candidate, FHD-909, is an oral SMARCA2 inhibitor being tested in a Phase 1 trial for SMARCA4-mutated cancers, including non-small cell lung cancer, in collaboration with Eli Lilly. The company also has discovery programs focused on other chromatin-related targets such as CBP, EP300, and ARID1B, using small molecule inhibitors and protein degraders. Its initial focus is oncology, with potential expansion into immunology and inflammation.
Based on the company's 10-K filed Mar 11, 2026.
Nasdaq · Healthcare
Foghorn Therapeutics Inc. (FHTX)
What Is the Price Target for FHTX?
SEPT Low Target
$2.00
SEPT Mid Target
$5.00
SEPT High Target
$5.00
Analyst Consensus
$5.00
Is FHTX a Buy or Sell Right Now?
Thesis
- •Revenue growing 36.8% YoY with STRONG trend — consistent growth.
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment stable.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for FHTX.
Start Free Trial →Is FHTX Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$5.00
30
Moat Score
NONE
1/9
Piotroski Score
-4.9
Altman Z-Score
What Is Smart Money Doing with FHTX?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →FHTX Growth Story
Revenue YoY
36.8%
3yr Revenue CAGR
17.1%
EPS Growth YoY
25.32%
FCF Growth YoY
15.0%
Revenue Trend
STRONG
Dark Pool Trades for FHTX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for FHTX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:25 | $2.07 | 11,473 | $$24K | BUY |
| 21:00:25 | $2.07 | 17,203 | $$36K | BUY |
| 21:00:00 | $2.07 | 2,100 | $$4K | BUY |
| 20:55:03 | $2.06 | 2,100 | $$4K | SELL |
| 20:53:07 | $2.06 | 1,000 | $$2K | BUY |
5 dark pool trades shown · $$70K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Foghorn Therapeutics Inc. (FHTX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →FHTX — frequently asked questions
What is FHTX stock price today?
Foghorn Therapeutics Inc. (FHTX) is at $2.07, up 0.98% (+$0.02) at the Nov 13, 2026 close.
Why is FHTX stock moving today?
Latest FHTX news — Nov 9, 2026: Foghorn Therapeutics Inc. filed a report on a major company event (Form 8-K)
What is the FHTX price target?
The average analyst price target for FHTX is $5.00, ranging from $2 to $5, based on 3 analysts. Latest: Guggenheim maintains on Oct 2, 2026.
What do analysts rate FHTX?
Analyst ratings for FHTX: 0 Buy, 2 Hold, 3 Sell — consensus Sell.
Did FHTX beat earnings?
FHTX last reported on Aug 6, 2026: EPS -$0.10 vs -$0.24 expected — a beat of 59.2%.
Does FHTX pay a dividend?
FHTX does not currently pay a dividend.
What are FHTX support and resistance levels?
Support: $1.79. Resistance: $2.70, $2.94, $3.21.
What are insiders doing with FHTX?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on FHTX?
Nov 9, 2026: Foghorn Therapeutics Inc. filed a report on a major company event (Form 8-K)